Drug interactions between Effient and omeprazole
| Results for the following 2 drugs: |
|---|
| Effient (prasugrel) |
| omeprazole |
Interactions between your selected drugs
omeprazole ↔ prasugrel
Applies to:omeprazole and Effient (prasugrel)
Coadministration with proton pump inhibitors or H2-receptor antagonists may modestly affect the pharmacokinetics of prasugrel, but does not appear to alter its antiplatelet effects. The proposed mechanism is delayed prasugrel dissolution due to increased gastric pH. In 24 healthy subjects, administration of a single 60 mg dose of prasugrel following pretreatment with lansoprazole 30 mg/day for 7 days resulted in a 29% decrease in the peak plasma concentration (Cmax) of the active metabolite of prasugrel and a nonsignificant (12%) decrease in the metabolite's systemic exposure (AUC) compared to administration of prasugrel alone. Lansoprazole had no significant effect on the response to prasugrel as measured by ADP-induced platelet aggregometry. Similarly, daily coadministration of ranitidine reduced the Cmax of the prasugrel active metabolite by 14%, but did not significantly change the AUC or Tmax. No dosage adjustment for prasugrel is necessary when coadministered with drugs that elevate gastric pH, including proton pump inhibitors and H2-receptor antagonists. However, administration of the 60 mg prasugrel loading dose without concomitant use of proton pump inhibitors may provide most rapid onset of action.
See also...
Drug Interaction Classification
The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
